COSM

Cosmos Health Inc. (COSM) | Rumor.io

Cosmos Health

COSM

Attention (50-day avg)0%

Attention rank (50-day avg)#684

Bullish sentiment (50-day avg)84%

Price to earnings ratio-0.58

Market capitalization37.2M

Earnings per share-0.67

Dividend yield (TTM)—

Revenue (annual)65.3M

Net income (annual)-19.1M

Social

What share of all stock conversation is about COSM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.02% +0.01	0.01% +0	0.01% +0	0% 0

Sep 30

$COSM is expected to be parabolic, with retail holding strong and potential short positions to be covered.
Cosmos Health Inc. has turned skepticism into momentum.
The company is instrumental to the 2029 guidance of $200.6 million in revenue, with projected gross profit, adjusted EBITDA, and net income.

Generated by AI

Sentiment

Of the messages about COSM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	94.62% +3.32	82.28% +0.14	85.92% +5.18	83.5% +8.18
Bearish	5.38% -3.32	17.72% -0.14	14.08% -5.18	16.5% -8.18

Bullish· Sep 29

The stock has outperformed the Healthcare sector by 96.39% over the last 3 months, indicating strong growth.
The company has delivered on its promises, releasing contracts that have led to real revenue growth, giving investors confidence in its ability to continue growing.
The stock has seen significant buying activity, with many investors confident that it will reach $20-$30 or even $1+ in the future, with some already seeing significant returns.

Bearish· Sep 28

The CEO's PR efforts are seen as meaningless and designed to manipulate the stock price, leading to potential losses for investors.
The company's financial projections are lacking, with profitability still not in sight, and the CEO's dilutive compensation is seen as a major issue preventing profitability.
The stock has been pumped and dumped repeatedly, with the current price drop being the result of a planned sell-off by short sellers.

Generated by AI

Topics

Of the messages about COSM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	100%	88.24%	32%	11.04%
Technical Analysis	0%	9.41%	4.23%	11.05%
Earnings	0%	0%	31.52%	2.26%
Analysts	0%	2.35%	32.25%	38.75%
Macro	0%	0%	0%	36.89%
Controversies	0%	0%	0%	0.01%

Announcements· Sep 28

Cosmos Health's Contract Manufacturing Division surpasses $20 million in implied revenue and $18 million in implied gross profit across a record 32.7 million-unit production pipeline.
The pipeline has grown approximately 6x since mid-2024, with a 31% increase in units added in September across two new agreements.
Cosmos Health has achieved margins over 90% in its Contract Manufacturing Division, with a significant increase in production capacity and revenue.

Controversies· Jan 26

Cosmos Health Inc. ($COSM) has retained Christian Levine Law Group to monitor trading irregularities.
This move comes after a significant price surge, with $COSM up 5% and $GNS up 820% after both companies hired the same law firm.
The timing of the announcement has sparked speculation, with some interpreting it as a response to the trading activity.

Technical Analysis· Feb 12

Cosmos Health Inc. ($COSM) is showing signs of a strong momentum trend, with multiple bullish indicators pointing to a potential breakout.
The stock's chart is exhibiting a tightening pattern, suggesting a buildup of strength for a potential move higher, with bulls eyeing higher resistance levels.
Technical analysis favors the buyers, with multiple bullish signals flashing on the chart, including a steady and solid momentum trend and strong support levels holding firm.

Generated by AI

Community

Of the messages about COSM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	68.28%	68.11%	68.15%	55.23%
Newcomers	31.72%	31.89%	31.85%	44.77%

Regulars· Sep 29

The company has released contracts that show a reality-based revenue stream, with a 100%+ price consolidation past the average, and the party hasn't even started yet.
Longs have seen a 340% return since June, and the momentum continues, with many buyers lining up due to positive fundamentals, strong volume, and amazing news.
The company has reported record annualized revenue of over $60 million, with a Q2 revenue of over $15 million, and the potential for a further $40 million or more in annual revenue, which would provide infrastructure for annualized revenue above $100 million.

Newcomers· Sep 30

The price of $COSM is expected to break through the 0.50 level, and some users predict it will reach $1 or more in value.

Generated by AI

News

COSM Continues to Grow Business

19h agoYahoo Finance

Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue

22h agoInvesting.com

Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue

22h agoMorningstar

Cosmos Health’s Cana unit surpasses $20M CMO pipeline

1d agoInvesting.com

Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline

* Contract manufacturing pipeline surpasses $20 million in implied revenue at wholly owned subsidiary Cana Laboratories, representing over $18 million in implied gross profit across the life of agreements * Gross margins of over 90% \- among the highest-margin revenue streams in the Company, with raw materials largely supplied by clients * Record production pipeline of more than 32.7 million units, up approximately sixfold since mid-2024 and close to threefold since the start of this year, with

2d agoYahoo Finance

Cosmos Health subsidiary secures 5.2M unit manufacturing deal

14d agoInvesting.com

Also Discussed

Investors talking about COSM also mention

#	Name	Attention
1	ComSovereign Holding Corp.COMS	0%new
2	Genius Group Ltd.GNS	0.37%-0.12
3	AMAM - Ambrx Biopharma Inc.	——
4	NVOS - Novo Integrated Sciences, Inc.	——
5	AMTD Digital Inc. ADRHKD	0%new
6	MGAM - Mobile Global Esports Inc.	——
7	PBLA - Panbela Therapeutics, Inc.	——
8	FingerMotion Inc.FNGR	0.08%+0.08
9	Magic Empire Global Ltd Class A Ordinary SharesMEGL	0%0
10	APRN - Blue Apron Holdings, Inc.	——

Cosmos Health Inc.

Healthcare
Medical Distribution

Cosmos Health Inc. is an international healthcare company focused on pharmaceuticals, nutraceuticals, and related consumer health products. Cosmos Health Inc. offers proprietary brands such as Sky Premium Life and Mediterranation, along with branded generics, over-the-counter medicines, food supplements, cosmetics, biocides, and medical devices. Through its subsidiaries, the company also manages wholesale distribution and manufacturing activities across Europe, serving retail pharmacies and healthcare distributors. Its business model combines product development, commercialization, and supply chain operations, with additional emphasis on research and development for nutraceuticals, specialized extracts, complex generics, and innovative OTC products. Cosmos Health Inc. operates across multiple healthcare segments, making it a diversified participant in the pharmaceutical distribution and consumer health markets.

Website

Location

5 Agiou Georgiou Str, Pilea

Thessaloniki, IL, 55438

Greece

Social

What share of all stock conversation is about COSM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0.02% +0.01	0.01% +0	0.01% +0	0% 0

Sep 30

$COSM is expected to be parabolic, with retail holding strong and potential short positions to be covered.
Cosmos Health Inc. has turned skepticism into momentum.
The company is instrumental to the 2029 guidance of $200.6 million in revenue, with projected gross profit, adjusted EBITDA, and net income.

Generated by AI

Sentiment

Of the messages about COSM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	94.62% +3.32	82.28% +0.14	85.92% +5.18	83.5% +8.18
Bearish	5.38% -3.32	17.72% -0.14	14.08% -5.18	16.5% -8.18

Bullish· Sep 29

The stock has outperformed the Healthcare sector by 96.39% over the last 3 months, indicating strong growth.
The company has delivered on its promises, releasing contracts that have led to real revenue growth, giving investors confidence in its ability to continue growing.
The stock has seen significant buying activity, with many investors confident that it will reach $20-$30 or even $1+ in the future, with some already seeing significant returns.

Bearish· Sep 28

The CEO's PR efforts are seen as meaningless and designed to manipulate the stock price, leading to potential losses for investors.
The company's financial projections are lacking, with profitability still not in sight, and the CEO's dilutive compensation is seen as a major issue preventing profitability.
The stock has been pumped and dumped repeatedly, with the current price drop being the result of a planned sell-off by short sellers.

Generated by AI

Topics

Of the messages about COSM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	100%	88.24%	32%	11.04%
Technical Analysis	0%	9.41%	4.23%	11.05%
Earnings	0%	0%	31.52%	2.26%
Analysts	0%	2.35%	32.25%	38.75%
Macro	0%	0%	0%	36.89%
Controversies	0%	0%	0%	0.01%

Announcements· Sep 28

Cosmos Health's Contract Manufacturing Division surpasses $20 million in implied revenue and $18 million in implied gross profit across a record 32.7 million-unit production pipeline.
The pipeline has grown approximately 6x since mid-2024, with a 31% increase in units added in September across two new agreements.
Cosmos Health has achieved margins over 90% in its Contract Manufacturing Division, with a significant increase in production capacity and revenue.

Controversies· Jan 26

Cosmos Health Inc. ($COSM) has retained Christian Levine Law Group to monitor trading irregularities.
This move comes after a significant price surge, with $COSM up 5% and $GNS up 820% after both companies hired the same law firm.
The timing of the announcement has sparked speculation, with some interpreting it as a response to the trading activity.

Technical Analysis· Feb 12

Cosmos Health Inc. ($COSM) is showing signs of a strong momentum trend, with multiple bullish indicators pointing to a potential breakout.
The stock's chart is exhibiting a tightening pattern, suggesting a buildup of strength for a potential move higher, with bulls eyeing higher resistance levels.
Technical analysis favors the buyers, with multiple bullish signals flashing on the chart, including a steady and solid momentum trend and strong support levels holding firm.

Generated by AI

Community

Of the messages about COSM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	68.28%	68.11%	68.15%	55.23%
Newcomers	31.72%	31.89%	31.85%	44.77%

Regulars· Sep 29

The company has released contracts that show a reality-based revenue stream, with a 100%+ price consolidation past the average, and the party hasn't even started yet.
Longs have seen a 340% return since June, and the momentum continues, with many buyers lining up due to positive fundamentals, strong volume, and amazing news.
The company has reported record annualized revenue of over $60 million, with a Q2 revenue of over $15 million, and the potential for a further $40 million or more in annual revenue, which would provide infrastructure for annualized revenue above $100 million.

Newcomers· Sep 30

The price of $COSM is expected to break through the 0.50 level, and some users predict it will reach $1 or more in value.

Generated by AI

Cosmos Health

Social

Sep 30

Bullish· Sep 29

Bearish· Sep 28

Announcements· Sep 28

Controversies· Jan 26

Technical Analysis· Feb 12

Regulars· Sep 29

Newcomers· Sep 30

COSM Continues to Grow Business

Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue

Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue

Cosmos Health’s Cana unit surpasses $20M CMO pipeline

Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline

Cosmos Health subsidiary secures 5.2M unit manufacturing deal

Also Discussed

Cosmos Health Inc.

Company Information

Location

COSM Continues to Grow Business

Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue

Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue

Cosmos Health’s Cana unit surpasses $20M CMO pipeline

Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline

Cosmos Health subsidiary secures 5.2M unit manufacturing deal

Also Discussed

Social

Sep 30

Bullish· Sep 29

Bearish· Sep 28

Announcements· Sep 28

Controversies· Jan 26

Technical Analysis· Feb 12

Regulars· Sep 29

Newcomers· Sep 30